Viewing Study NCT05421858


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-04-18 @ 1:54 AM
Study NCT ID: NCT05421858
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-06-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
Sponsor: Basilea Pharmaceutica
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module